Sanara Medtech (NASDAQ: SMTI) revenue
Sanara Medtech reported revenue of $103.1m for fiscal 2025, 19.0% more than in fiscal 2024 ($86.7m). Since fiscal 2016 its revenue has grown by 1,772.2%, an average growth of 38.5% a year.
Sanara Medtech has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2018, −7.4%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $103.1m | +19.0% | $7.3m | 7.1% |
| 2024 | $86.7m | +33.4% | $1.3m | 1.5% |
| 2023 | $65.0m | +41.8% | −$4.2m | −6.5% |
| 2022 | $45.8m | +89.9% | −$12.5m | −27.3% |
| 2021 | $24.1m | +54.9% | −$7.4m | −30.6% |
| 2020 | $15.6m | +32.5% | −$5.0m | −32.3% |
| 2019 | $11.8m | +101.6% | −$2.7m | −23.3% |
| 2018 | $5.8m | −7.4% | −$0.5m | −8.6% |
| 2017 | $6.3m | +14.5% | $0.1m | 1.9% |
| 2016 | $5.5m | — | −$0.3m | −4.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Sanara Medtech revenue compared with its sector
By revenue for its latest fiscal year, Sanara Medtech ranks 284th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Sanara Medtech, 19.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 282nd | Zevra Therapeutics | $106.5m | 350.9% |
| 283rd | Zymeworks | $106.0m | 38.9% |
| 284th | Sanara Medtech | $103.1m | 19.0% |
| 285th | Sutro Biopharma | $102.5m | 65.2% |
| 286th | Beta Bionics | $100.3m | 53.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Sanara Medtech
- How much revenue did Sanara Medtech make in fiscal 2025?
- Sanara Medtech reported revenue of $103.1m for fiscal 2025, compared with $86.7m in fiscal 2024.
- How much has the revenue of Sanara Medtech grown?
- Between fiscal 2016 and fiscal 2025 it went from $5.5m to $103.1m: 1,772.2% more, an average growth of 38.5% a year.
- What was the best year for revenue at Sanara Medtech?
- Of its last 10 fiscal years, fiscal 2025, with $103.1m.
- Where does Sanara Medtech rank in its sector by revenue?
- It ranks 284th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Sanara Medtech come from?
- From the annual report (Form 10-K) that Sanara Medtech files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Sanara Medtech files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Sanara Medtech: the Sanara Medtech page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.